Latest News
Pennon to take hit on costs of legal dispute with Interserve
Utility company Pennon said it was on track to meet full year expectations but warned that its energy recovery facility in Glasgow would cost £95m more than the original budget figure of £155m.
GKN welcomes Dana's cash offer, retracts director quotes
GKN has received an increased cash offer for its Driveline business from US-based Dana, while also being forced to retract directors' statements quoted in Sunday newspapers about the hostile takeover bid from Melrose Industries.
Angle PMT test out-performs in diagnosing ovarian cancer
A blood test for ovarian cancer by UK medical technology company Angle has achieved a 95. 1% correct prediction of cancer.
Shire teams up with NanoMedSyn for enzyme replacement therapy research
Rare disease-focussed pharmaceuticals firm Shire announced on Monday that it and biotechnology specialist NanoMedSyn have entered into a preclinical research collaboration to evaluate a potential enzyme replacement therapy using NanoMedSyn's proprietary synthetic derivatives named AMFA.
Inchcape buys Central America dealership for £201m
Car seller Inchcape on Monday said it had bought Suzuki-focused Central American dealer Grupo Rudelman for $284m (£201m), on a cash-free and debt-free basis.
Smurfit Kappa rejects improved offer from IPC, JD Sports agrees to acquire The Finish Line
London open.
London pre-open: FTSE looking to rebound, Smurfit and GKN continue to resist
London stocks are predicted to open slightly higher on Monday morning as dealmaking dominated the corporate news again.
Monday newspaper round-up: NHS funding, new car sales, Provident Financial, Carillion, GKN, Melrose
Jeremy Hunt called health funding “crazy” yesterday as he launched a political offensive for a ten-year NHS spending deal and backed moves for a ring fenced tax. The health secretary, who has emerged as one of the cabinet’s most powerful figures in recent months, said that GPs and hospitals had been subjected to “feast or famine” in the past two decades. - The Times.
Smurfit Kappa rejects renewed offer from International Paper
Smurfit Kappa said it had rejected an increased offer from International Paper Company (IPC) which valued it at €37. 54, saying it “fundamentally undervalues the group”.